Cutler Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-7,000
Closed -$9K 5744
2017
Q3
$9K Sell
7,000
-400
-5% -$16.8K ﹤0.01% 3903
2017
Q2
$26K Buy
7,400
+600
+9% +$22.8K ﹤0.01% 3149
2017
Q1
$16K Sell
6,800
-700
-9% -$22.2K ﹤0.01% 3569
2016
Q4
$14K Sell
7,500
-7,300
-49% -$226K ﹤0.01% 3847
2016
Q3
$18K Buy
14,800
+1,500
+11% +$45.3K ﹤0.01% 3544
2016
Q2
$17K Sell
13,300
-28,400
-68% -$726K ﹤0.01% 3543
2016
Q1
$22K Sell
41,700
-7,700
-16% -$188K ﹤0.01% 3179
2015
Q4
$94K Buy
+49,400
New +$1.42M 0.01% 1834

Other funds holding RGEN

Cutler Group's RGEN Position: Q3 2016 in Review

Cutler Group sold out of Repligen (RGEN) in Q3 2016, closing a stake of 1,401 shares — an estimated $42.3K sold.

Cutler Group first reported a position in RGEN in Q2 2016 and held it in 1 quarter. The position peaked at $38K in Q2 2016. 181 funds tracked by Wall St. Rank hold RGEN as of Q3 2016.

  • Cutler Group reported no remaining Repligen position as of Q3 2016 after selling out during the quarter.
  • Cutler Group sold 1,401 Repligen shares in Q3 2016, an estimated $42.3K.
  • Cutler Group first reported a position in Repligen in Q2 2016 and held it in 1 quarter.
  • Cutler Group's Repligen position peaked at $38K in Q2 2016.
  • 181 funds tracked by Wall St. Rank held Repligen as of Q3 2016.

Based on Cutler Group's 13F filing for Q3 2016, filed 11 Oct 2016.